Biogen Pharmachem Complete Financial Statements
BIOGEN • Review detailed financials to uncover trends, confirm thesis & journal trades
11 Years of Data
2025 - 2015
Complete Financial Data Export
Export complete financial statements for Biogen Pharmachem (BIOGEN).
Downloads include all available records across all periods.
Profitability Ratios
Balance Sheet Ratios
Equity Ratio
100.00%
2025 data
Asset Turnover
0.01
2025 data
Year-over-Year Growth Analysis
Comparing March 2025 vs Period
Revenue Growth
+200.0%
Year-over-Year
Expense Growth
-50.0%
Year-over-Year
Assets Growth
+61.4%
Year-over-Year
Equity Growth
+61.4%
Year-over-Year
Operating Cash Flow Growth
-150.0%
Year-over-Year
Investing Cash Flow Growth
-1550.0%
Year-over-Year
Income Statement
Periods
₹ Crores
| Particulars | None | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3 | 1 | 2 | 1 | 3 | 2 | 0 | 1 | 0 | 0 | 0 | 0 |
| Expenses | 1 | 2 | 1 | 1 | 3 | 3 | 0 | 1 | 7 | 0 | 0 | 0 |
| EBITDA | 3 | 0 | 2 | 1 | 0 | -2 | 0 | 0 | -7 | 0 | 0 | 0 |
| Operating Profit Margin % | 0.00% | 0.00% | 0.00% | 0.00% | -1.00% | -99.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 3 | 0 | 2 | 1 | 0 | -2 | 0 | 0 | -7 | 0 | 0 | 0 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 3 | 0 | 2 | 1 | 0 | -2 | 0 | 0 | -7 | 0 | 0 | 0 |
| Earnings Per Share (₹) | 0.00 | 0.00 | 0.03 | 0.01 | 0.00 | -0.02 | 0.00 | 0.00 | -0.10 | 0.00 | 0.00 | 0.00 |
Related Pages for Biogen Pharmachem
Additional stock information and data for BIOGEN
Balance Sheet
Years
Annual Data
₹ Crores
| Particulars | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||
| Total Assets | 92 | 57 | 55 | 55 | 54 | 56 | 58 | 56 | 63 | 69 | 74 |
| Current Assets | 3 | 0 | 0 | 2 | 3 | 8 | 8 | 7 | 0 | 14 | 29 |
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Work in Progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 24 | 5 | 9 | 7 | 10 | 6 | 6 | 4 | 22 | 14 | 23 |
| Other Assets | 68 | 51 | 46 | 48 | 45 | 50 | 51 | 52 | 41 | 55 | 51 |
| LIABILITIES | |||||||||||
| Total Liabilities | |||||||||||
| Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 2 | 2 | 8 | 9 |
| Non-Current Liabilities | |||||||||||
| SHAREHOLDERS' EQUITY | |||||||||||
| Total Equity | 92 | 57 | 55 | 54 | 54 | 56 | 54 | 54 | 61 | 61 | 61 |
| Share Capital | 65 | 65 | 65 | 65 | 65 | 65 | 65 | 65 | 65 | 65 | 65 |
| Reserves & Surplus | -9 | -9 | -11 | -11 | -11 | -10 | -11 | -11 | -4 | -4 | -4 |
Cash Flow Statement
Periods
₹ Crores
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | -1 | 2 | 2 | 1 | 4 | -1 | 0 | -14 | 0 | 5 | -7 |
| Investing Activities | -33 | -2 | -2 | -1 | -4 | 2 | -1 | 14 | 4 | 17 | 17 |
| Financing Activities | 36 | 0 | 0 | 0 | 0 | 0 | 1 | -1 | -4 | -22 | -11 |
| Net Cash Flow | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1 |